Coronavirus Disease 2019 Vaccine Dosage in Children, Adolescents, and Young Adults: Is Less More?

By sjmartinez • May 1, 2022

Tobin NH, Yang OO. Coronavirus Disease 2019 Vaccine Dosage in Children, Adolescents, and Young Adults: Is Less More? Open Forum Infect Dis. 2022 May 1;9(7):ofac222. doi: 10.1093/ofid/ofac222. PMID: 35821728; PMCID: PMC9272428.

Tags: Adolescents, Boosters, children, covid-19, covid-19 vaccination, Covid-19 vaccination associated myocarditis, Dosage, Dosing intervals, Infectious Diseases, Myocarditis, Publications, young adults

Related Posts

Lessons learned from COVID-19 to overcome challenges in conducting outpatient clinical trials to find safe and effective therapeutics for the next infectious pandemic

Oh MA, Currier J, Khan A, Mylonakis E, Newell M, Ignacio RB, Jilg N, Safdar B, Merck LH, Smith DM. Lessons learned from COVID-19 to[...]

ACTIV trials: cross-trial lessons learned for master protocol implementation

Keshtkar-Jahromi M, Adam SJ, Brar I, Chung LK, Currier JS, Daar ES, Davey VJ, Denning ET, Gelijns AC, Higgs ES, Jagannathan P, Javan AC, Jensen[...]

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative

Wohl DA, Adam SJ, Gibbs KW, Moskowitz AL, Ortel TL, Singh U, Jilg N, Evering TH, Fischer WA 2nd, Taiwo BO, Daar ES, Lindsell CJ,[...]